Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease

Non-Invasive Assessment of Liver Disease in Patients with NAFLD

(2019) Laurent Castera et al.   GASTROENTEROLOGY

Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice

(2019) Jiang-Hua Zhou et al.   WORLD JOURNAL OF GASTROENTEROLOGY

MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis

(2019) Kee‐Huat Chuah et al.   LIVER INTERNATIONAL

New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

(2019) Jérôme Boursier et al.   JOURNAL OF HEPATOLOGY

Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram

(2019) Yu-Jie Zhou et al.   United European Gastroenterology Journal

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis

(2019) Donghee Kim et al.   JOURNAL OF GASTROENTEROLOGY

PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels

(2019) Dan‐Qin Sun et al.   LIVER INTERNATIONAL

Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease

(2019) Wen‐Yue Liu et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH

(2018) J. Boursier et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

(2018) Eduardo Vilar-Gomez et al.   JOURNAL OF HEPATOLOGY

Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients

(2017) Tamara Milovanovic Alempijevic et al.   Canadian Journal of Gastroenterology and Hepatology

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

(2016) Vlad Ratziu et al.   GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

(2016)   JOURNAL OF HEPATOLOGY

Nonalcoholic fatty liver disease

(2015) Elizabeth M. Brunt et al.   Nature Reviews Disease Primers

Harmonizing the Metabolic Syndrome

(2009) K.G.M.M. Alberti et al.   CIRCULATION

Liver biopsy

(2008) Don C. Rockey et al.   HEPATOLOGY

Non-invasive evaluation of liver fibrosis using transient elastography

(2008) Laurent Castera et al.   JOURNAL OF HEPATOLOGY